Skip to main navigation Skip to search Skip to main content

Investigating the contribution of collagen to the tumor biomechanical phenotype with noninvasive magnetic resonance elastography

  • Jin Li
  • , Konstantinos Zormpas-Petridis
  • , Jessica K.R. Boult
  • , Emma L. Reeves
  • , Andreas Heindl
  • , Maria Vinci
  • , Filipa Lopes
  • , Craig Cummings
  • , Caroline J. Springer
  • , Louis Chesler
  • , Chris Jones
  • , Jeffrey C. Bamber
  • , Yinyin Yuan
  • , Ralph Sinkus
  • , Yann Jamin
  • , Simon P. Robinson

Research output: Contribution to journalArticlepeer-review

Abstract

Increased stiffness in the extracellular matrix (ECM) contributes to tumor progression and metastasis. Therefore, stromal modulating therapies and accompanying biomarkers are being developed to target ECM stiffness. Magnetic resonance (MR) elastography can noninvasively and quantitatively map the viscoelastic properties of tumors in vivo and thus has clear clinical applications. Herein, we used MR elastography, coupled with computational histopathology, to interrogate the contribution of collagen to the tumor biomechanical phenotype and to evaluate its sensitivity to collagenase-induced stromal modulation. Elasticity (Gd) and viscosity (Gl) were significantly greater for orthotopic BT-474 (Gd ¼ 5.9 ± 0.2 kPa, Gl ¼ 4.7 ± 0.2 kPa, n ¼ 7) and luc-MDA-MB-231-LM2-4 (Gd ¼ 7.9 ± 0.4 kPa, Gl ¼ 6.0 ± 0.2 kPa, n ¼ 6) breast cancer xenografts, and luc-PANC1 (Gd ¼ 6.9 ± 0.3 kPa, Gl ¼ 6.2 ± 0.2 kPa, n ¼ 7) pancreatic cancer xenografts, compared with tumors associated with the nervous system, including GTML/Trp53KI/KI medulloblastoma (Gd ¼ 3.5 ± 0.2 kPa, Gl ¼ 2.3 ± 0.2 kPa, n ¼ 7), orthotopic luc-D-212-MG (Gd ¼ 3.5 ± 0.2 kPa, Gl ¼ 2.3 ± 0.2 kPa, n ¼ 7), luc-RG2 (Gd ¼ 3.5 ± 0.2 kPa, Gl ¼ 2.3 ± 0.2 kPa, n ¼ 5), and luc-U-87-MG (Gd ¼ 3.5 ± 0.2 kPa, Gl ¼ 2.3 ± 0.2 kPa, n ¼ 8) glioblastoma xenografts, intracranially propagated luc-MDA-MB-231-LM2-4 (Gd ¼ 3.7 ± 0.2 kPa, Gl ¼ 2.2 ± 0.1 kPa, n ¼ 7) breast cancer xenografts, and Th-MYCN neuroblastomas (Gd ¼ 3.5 ± 0.2 kPa, Gl ¼ 2.3 ± 0.2 kPa, n ¼ 5). Positive correlations between both elasticity (r ¼ 0.72, P < 0.0001) and viscosity (r ¼ 0.78, P < 0.0001) were determined with collagen fraction, but not with cellular or vascular density. Treatment with collagenase significantly reduced Gd (P ¼ 0.002) and Gl (P ¼ 0.0006) in orthotopic breast tumors. Texture analysis of extracted images of picrosirius red staining revealed significant negative correlations of entropy with Gd (r ¼ -0.69, P < 0.0001) and Gl (r ¼ -0.76, P < 0.0001), and positive correlations of fractal dimension with Gd (r ¼ 0.75, P < 0.0001) and Gl (r ¼ 0.78, P < 0.0001). MR elastography can thus provide sensitive imaging biomarkers of tumor collagen deposition and its therapeutic modulation. Significance: MR elastography enables noninvasive detection of tumor stiffness and will aid in the development of ECM-targeting therapies.

Original languageEnglish (US)
Pages (from-to)5874-5883
Number of pages10
JournalCancer Research
Volume79
Issue number22
DOIs
StatePublished - Nov 15 2019
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Investigating the contribution of collagen to the tumor biomechanical phenotype with noninvasive magnetic resonance elastography'. Together they form a unique fingerprint.

Cite this